The American Journal of Medicine
Volume 76, Issue 6 , Pages 989-998 , June 1984

Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals

  • B.Robert Meyer, M.D.

      Affiliations

    • From the Departments of Pharmacology and Medicine, Cornell University Medical College, the Environmental Sciences Laboratory, Mount Sinai Medical Center, New York, New York,
    • ,
  • Alf Fischbein, M.D.

      Affiliations

    • From the Departments of Pharmacology and Medicine, Cornell University Medical College, the Environmental Sciences Laboratory, Mount Sinai Medical Center, New York, New York,
  • Kenneth Rosenman, M.D.

      Affiliations

    • From the Occupational Health Program, New Jersey State Health Department, Trenton, New Jersey.

,Accepted 2 December 1983.

References 

  1. Department of Health, Education and Welfare . Research needs in nephrology and urology. NIH publication no. 78-1480. 1978;Vol I:
  2. Oliver T. Lead poisoning. London: Lewis; 1914;
  3. Marsden HB, Wilson VK. Lead poisoning in children. Br Med J. 1955;1:324–326
  4. Chisolm JJ. Aminoaciduria as a manifestation of renal tubular injury in lead intoxication and a comparison with patterns of aminoacidurfa seen in other diseases. J Pediatr. 1962;60:1–17
  5. Aub JC, Fairhall LT, Minot AS, Reznikoff P. Lead poisoning. Medicine (Baltimore). 1925;4:1–250
  6. Kazantzis G, Schiller KFR, Asscher AW, Drew RG. Albuminuria and the nephrotic syndrome following exposure to mercury and its compounds. Q J Med. 1962;31:403–418
  7. Doolan PD, Hess WC, Kyle LH. Acute renal insufficiency due to dichloride of mercury, observations of gastrointestinal hemorrhage and B.A.L. therapy. N Engl J Med. 1953;249:273–276
  8. Becker CG, et al. Nephrotic syndrome after contact with mercury. Arch Inst Med. 1963;110:178–186
  9. Carruthers M, Smith B. Evidence of cadmium toxicity in a population living in a zinc mining area. Lancet. 1979;I:845–847
  10. Bernard A, Goret A, Roels H, Buchet JP, Lawerys R. Experimental confirmation in rats of the mixed type of proteinuria observed in workers exposed to cadmium. Toxicology. 1978;10:369–375
  11. Kendrey G, Roe FJC. Cadmium toxicology. Lancet. 1969;I:1206–1207
  12. von Scheele C, Althoff P, Kempi V, Schelin U. Nephrotic syndrome due to subacute glomerulonephritis—association with hydrocarbon exposure?. Acta Med Scand. 1976;200:427–429
  13. Baerg RD, Kimberg DV. Centrilobular hepatic necrosis and acute renal failure in solvent sniffers. Ann Intern Med. 1970;73:713–720
  14. Litt IF, Cohen MI. Danger … vapor harmful: spot-remover sniffing. N Engl J Med. 1969;281:543–544
  15. Ravnskov U. Acute glomerulonephritis and exposure to organic solvents in father and daughter. Acta Med Scand. 1979;205:581–582
  16. Gutch CF, Tomhave WG, Stevens SC. Acute renal failure due to inhalation of trichloroethylene. Ann Intern Med. 1965;63:128–134
  17. Guild WR, Young JV, Merrill JP. Anuria due to carbon tetrachloride intoxication. Ann Intern Med. 1958;48:1221–1227
  18. Ehrenreich T. Renal disease from exposure to solvents. Ann Clin Lab Sci. 1977;7:6–16
  19. Berndt WO. Use of renal function tests in the evaluation of nephrotoxic effects. In:  Hook JB editors. Toxicology of the kidney. New York: Raven Press; 1981;p. 1–29
  20. Balazs T, Hatch A, Zawidzka Z, Grice HC. Renal tests in toxicity studies in rats. Toxicol Appl Pharmacol. 1963;5:661–674
  21. Price RG. Urinary enzymes, nephrotoxicity and renal disease. Toxicology. 1982;23:99–134
  22. Maruhn D. Evaluation of urinary enzyme patterns in patients with kidney diseases and primary benign hypertension. Curr Probl Clin Biochem. 1979;9:135–149
  23. Piperno E. Detection of drug induced nephrotoxicity with urinalysis and enzymuria assessment. In:  Hook JB editors. Toxicology of the kidney. New York: Raven Press; 1981;p. 31–55
  24. Sherman RL, Drayer DE, Leyland-Jones BR, Reidenberg MM. N-acetyl-β-glucosaminidase and β2-microglobulin: their urinary excretion in patients with renal parenchymal disease. Arch Intern Med. 1983;143:1183–1185
  25. Wellwood JM, Eliis BG, Price RG, Hammond K, Thompson AE, Jones NF. Urinary N-acetyl-beta-D-glucosaminidase activities in patients with renal disease. Br Med J. 1975;3:408–411
  26. Price RG. Urinary N-acetyl-beta-glucosaminidase (NAG) as an indicator of renal disease. Curr Probl Clin Biochem. 1979;9:150–163
  27. Hultberg B, Ravnskov U. The excretion of N-acetyl-beta glucosaminidase in glomerulonephritis. Clin Nephrol. 1981;15:33–38
  28. Kunin CM, Chesney RW, Craig WA, et al. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease. Pediatics. 1978;62:751–760
  29. Vigano A, Cavanna G, Capodaglio P, Assael BM, Salmona M. Methodological and clinical aspects of urinary N-acetyl-glucosaminidase in pediatric subjects. Biochem Med. 1981;25:26–33
  30. Price RG, Dance N, Richards B, Cattell WR. The excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase following surgery to the kidney. Clin Chim Acta. 1970;27:65–72
  31. Lockwood TD, Bosmann HB. The use of urinary N-acetyl-beta-glucosaminidase in human renal toxicology. Toxicol Appl Pharmacol. 1979;49:323–336
  32. Eisinger J, Blumberg WE, Fischbein A, Lilis R, Selikoff IJ. Zinc protoporphyrin in blood as a biological indicator of chronic lead intoxication. J Environ Pathol Toxicol. 1978;1:897–910
  33. Jones BR, Bhalla RB, Mladek J, et al. Comparison of methods of evaluating nephrotoxicity of cis-platinum. Clin Pharmacol Ther. 1980;27:557–562
  34. Leaback DE, Walker DG. The fluorimetric assay of N-acetyl-beta-glucosaminidase. Biochem J. 1961;78:151–156
  35. Colquhoun D. Lectures on biostatistics: an introduction to statistics with applications in biology and medicine. In: Oxford: Clarendon Press; 1971;p. 103
  36. Zar JH. Biostatistical analysis. In: Englewood Cliffs, New Jersey: Prentice-Hall; 1974;p. 79–84
  37. Ellis BG, Price RG, Topham JC. The effect of tubular damage by mercuric chloride on kidney function and some urinary enzymes in the dog. Chem Biol Interact. 1973;7:101–113
  38. Ellis BG, Price RG, Topham JC. The effect of papillary damage by ethyleneimine on kidney function and some urinary enzymes in the dog. Chem Biol Interact. 1973;7:131–142
  39. Ellis BG, Price RG. Urinary enzyme excretion during renal papillary necrosis induced in rats with ethyleneimine. Chem Biol Interact. 1975;11:473–482
  40. Adelman RD, Spangler WL, Beason F, Ishizaki G, Conzelman GM. Furosemide enhancement of experimental gentamicin nephrotoxicity: comparison of functional and morphological changes with activities of urinary enzymes. J Infect Dis. 1979;140:342–352
  41. Wellwood JM, Davies D, Leighton M, Thompson AE. Urinary N-acetyl-beta-D-glucosaminidase assay in renal transplant recipients. Transplantation. 1978;26:396–400
  42. Whiting PH, Nicholas AJ, Catto GRD, Edward N, Engeset J. Patterns of N-acetyl-beta-D-glucosaminidase excretion after renal transplantation. Clin Chim Acta. 1980;108:1–7
  43. Wellwood JM, Simpson PM, Tighe JR, Thompson AE. Evidence of gentamicin nephrotoxicity in patients with renal allografts. Br Med J. 1975;3:278–281
  44. Hartman BJ, Powell JH, Nash T, Reidenberg MM. Evidence for prior renal injury in patients with normal serum creatinine who develop gentamicin nephrotoxicity (abstr). Clin Res. 1981;29:501A
  45. Mansell MA, Jones NF, Ziroyanis PN, Marsen WS. N-acetyl-beta-glucosaminidase: a new approach to the screening of hypertensive patients for renal disease. Lancet. 1978;II:803–805
  46. Alderman MH, Melcher L, Drayer DE, Reidenberg MM. Evidence that minimal renal damage is common in essential hypertension and improves with therapy (abstr). Clin Res. 1982;30:486A
  47. Proctor RA, Kunin CM. Salicylate-induced enzymuria. Am J Med. 1978;65:987–993
  48. Merle LJ, Reidenberg MM, Camacho MT, Jones BR, Drayer DE. Renal injury in patients with rheumatoid arthritis treated with gold. Clin Pharmacol Ther. 1980;28:216–222
  49. Prescott LF, Ansari S. The effects of repeated administration of mercuric chloride on exfoliation of renal tubular cells and urinary glutamic-oxaloacetic transaminase activity in the rat. Toxicol Appl Pharmacol. 1969;14:97–107
  50. Stroo WE, Hook JB. Renal functional correlates of methyl mercury intoxication: interactions with acute mercuric chloride toxicity. Toxicol Appl Pharmacol. 1977;42:399–410
  51. Fowler BA, Brown HW, Lucier GW, Krigman MR. The effects of chronic methyl mercury exposure on the lysosome system of rat kidney. Lab Invest. 1975;32:313–322
  52. Goldwater LJ. Kidney injury after chronic exposure to inorganic mercury. Arch Industr Hygiene Occup Med. 1953;8:588
  53. Friberg L, Hammarstrom S, Nystrom A. Kidney injury after chronic exposure to inorganic mercury. Arch Industr Hygiene Occup Med. 1953;8:149–153
  54. Joselow MM, Goldwater LJ. Absorption and excretion of mercury in man. Arch Environ Health. 1967;15:155–159
  55. Foa V, Carini L, Amante L, et al. Patterns of some lysosomal enzymes in the plasma and of proteins in the urine of workers exposed to inorganic mercury. Int Arch Occup Environ Health. 1976;37:115–124
  56. Iesato K, Wakashin M, Wakashin Y, Tojo S. Renal tubular dysfunction in minimata disease. Ann Intern Med. 1977;86:731–737
  57. World Health Organization . Environmental health criteria: mercury. Geneva: World Health Organization; 1976;
  58. Wedeen RP. The role of lead in renal failure. Clin Exp Dialysis Apheresis. 1982;6:113–146
  59. Mayers MR. Industrial exposure to lead. Occup Med. 1947;3:77–83
  60. Goyer RA, Leonard DL, Moore JF, et al. Lead dosage and the role of the intra-nuclear inclusion body. Arch Environ Health. 1970;20:705–711
  61. Griffith JQ, Lindauer MA. The effect of chronic lead poisoning on arterial blood pressure in rats. Am Heart J. 1944;28:295–297
  62. Sun CN, Goyer RA, Mellies M, Yin MW. The renal tubule in experimental lead intoxication. Arch Pathol. 1966;82:156–163
  63. Krigman MR, Crane D, Goyer RA. Lysosomal alterations in lead nephropathy (abstr). In: 10th ed. Fed Proc. 27:1968;p. 410
  64. Goyer RA. The renal tubule in lead poisoning I: mitochondrial swelling and aminoaciduria. Lab Invest. 1968;19:71–77
  65. Goyer RA, Krall A, Kinball JP. The renal tubule in lead poisoning II: in vitro studies of mitochondrial structure and function. Lab Invest. 1968;19:78–83
  66. Chiodi H, Sammartino RA. Nephrotoxic and renotropic effects of lead on white rats and its prevention by B.A.L.. Nature. 1947;160:680–681
  67. Pardoe AU. Renal function in lead poisoning. Br J Pharmacol. 1952;7:349–357
  68. Aviv A, John E, Bernstein J, Goldsmith DI, Spitzer A. Lead intoxication during development: its late effects on kidney function and blood pressure. Kidney Int. 1980;17:430–437
  69. Tange JD, Hayward NJ, Bremner DA. Renal lesions in experimental plumbism and their clinical implications. Australas Ann Med. 1965;14:49–56
  70. Hirsch GH. Effect of chronic lead treatment on renal function. Toxicol Appl Pharmacol. 1973;25:84–93
  71. Port CD. Acute and chronic lead nephropathy. Animal model: lead nephropathy in gerbils following short- and long-term administration of lead acetate. Am J Pathol. 1976;85:519–522
  72. Henderson DA. A follow-up of cases of plumbism in children. Australas Ann Med. 1954;3:219–224
  73. Henderson DA. Chronic nephritis in Queensland. Australas Ann Med. 1955;4:163–177
  74. Tepper LB. Renal function subsequent to childhood plumbism. Arch Environ Health. 1963;7:76–85
  75. Chisolm JJ. Acute and chronic effects of lead on the kidney. Lead conference, Mayaquez, Puerto Rico, February 16–18, 1970. In: Lead and the kidney. 10th ed.  Goyer RA editors. Curr Top Pathol. 55:1971;p. 147–176
  76. Campbell BC, Beattie AD, Moore MR, Goldberg A, Reid AG. Renal insufficiency associated with excessive lead exposure. Br Med J. 1977;1:482–485
  77. Ramirez-Cervantes B, Embree JW, Hine CH, et al. Health assessment of employees with different body burdens of lead. J Occup Med. 1978;20:610–617
  78. Lilis R, Valciukas J, Fischbein A, et al. Renal function impairment in secondary lead smelter workers: correlations with zinc protoporphyrin and blood lead levels. J Environ Pathol Toxicol. 1979;2:1447–1474
  79. Batuman V, Maesaka JK, Haddad B, et al. The role of lead in gout nephropathy. N Engl J Med. 1981;304:520–523
  80. Atkinson RM, Caisey JD, Currie JP, et al. Subacute toxicity of cephaloridine to various species. Toxicol Appl Pharmacol. 1966;8:407–428
  81. Balazs T. Development of tissue resistance to toxic effects of chemicals. Toxicology. 1974;2:247–255
  82. Scott JT, Denman AM, Dorling J. Renal irritation caused by salicylates. Lancet. 1963;I:344–348
  83. Reidenberg MM, Powers DV, Sevy RW, Bello CT. Acute renal failure due to nephrotoxins. Am J Med Sci. 1964;247:25–29
  84. Crisp AJ, Bhalla AK, Hoffbrand BI. Acute tubular necrosis after exposure to diesel oil. Br Med J. 1979;2:177
  85. Drayer DE, Reidenberg MM. Metabolism of tetralin and toxicity of cuprex in man. Drug Metab Dispos. 1973;1:577–579
  86. Kluwe WM. The nephrotoxicity of low molecular weight halogenated alkane solvents, pesticides, and chemical intermediates. In:  Hook JB editors. Toxicology of the kidney. New York: Raven Press; 1981;p. 179–225
  87. Kluwe WM, Hook JB. Metabolic activation of nephrotoxic halolakanes. In: 10th ed. Fed Proc. 39:1980;p. 3129–3133
  88. Beirne GJ, Brennan JT. Glomerulonephritis associated with hydrocarbon solvents. Arch Environ Health. 1972;25:365–369
  89. Zimmerman SW, Groehler K, Beirne GJ. Hydrocarbon exposure and chronic glomerulonephritis. Lancet. 1975;II:199–201
  90. Lagrue G. Hydrocarbon exposure and chronic glomerulonephritis. Lancet. 1976;I:1191
  91. Ravnskov U, Forsberg B, Skerfving S. Glomerulonephritis and exposure to organic solvents. Acta Med Scand. 1979;205:575–579
  92. Finn R, Fennerty AG, Ahmad R. Hydrocarbon exposure and glomerulonephritis. Clin Nephrol. 1980;14:173–175

☆ This work was supported in part by National Institute of Environmental Health Sciences Center Grant ES00928, GM 07488 (Dr. Meyer's fellowship), and the Supportive Care Service of the New York Hospital-Cornell Medical Center.

PII: 0002-9343(84)90847-7

The American Journal of Medicine
Volume 76, Issue 6 , Pages 989-998 , June 1984

Article Tools